...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Expectations for the AGM?

KayakerBC,

At this point I am concerned  not sure DM has the ability to close any type of  deal with a Major BP, I would take any major BP  deal ,  I really really hope I am dead wrong and a rabbit will be pulled out of the hat but this 10 to 15 year saga of BP discusions is getting too old for this long term holder of Zen and RVX,  I would like to see a major  BP deal,(not a co development BS deal) Would legimatmize the science for both companies, GLTA, 12 days and counting....

Share
New Message
Please login to post a reply